secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001737287-23-000060
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Eric Schmidt resigns effective August 2, 2023; search underway
------------------------------------------------------------------

- Eric Schmidt, Ph.D., CFO, principal financial and accounting officer, resigned effective August 2, 2023.
- Resignation voluntary to spend more time with family.
- Company has initiated a search for a new CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000060/0001737287-23-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728723000060/allo-20230609.htm
  HTML page:      https://secwatch.observer/filing/0001737287-23-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer